Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Staffan Encrantz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Badawi - $957K in SGHT purchases and sales in the last 12 months
- Alison Bauerlein - $666K in SGHT purchases and sales in the last 12 months
- Jeremy B. Hayden - $635K in SGHT purchases and sales in the last 12 months
- David Badawi - $245K in SGHT purchases and sales in the last 12 months
- James Rodberg - $203K in SGHT purchases and sales in the last 12 months
- Brenton Taylor - $159K in SGHT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Staffan Encrantz?
Staffan Encrantz is a corporate insider of Sight Sciences, Inc. (SGHT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Staffan Encrantz last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 4 filings going back to 2024.
Has Staffan Encrantz been buying or selling stock?
Recorded transactions: 3 open-market purchases ($2.24M) and 1 open-market sale ($2.06M) across all tracked filings.